The battery will last up to 3 years on this device.  The device is set up to measure atrial arrhythmias (irregular heart rhythms in the upper chambers) imageand monitor patients for suspected suspected arrhythmias.  It requires a small outpatient procedure.  The Patient assistant device is waived over the device in case of fainting or to record heartbeats at any time. 

Patients wearing the devices have been able to have their conditions detected, one for example needed a pacemaker, while another needed medication.  Some hearts have been beating too slow, some too fast, at any rate capturing the data at the time of the fainting spell is enabling physicians to diagnose and get to the real cause of the fainting spells.

The device can be the answer if worn and information is sent to the Patient Assistant upon a syncope or fainting spell.  This could certainly be a lot more convenient than wearing a device on the outside of your body it appears.  BD

imageMedtronic, Inc. (NYSE: MDT) today announced the commercial availability of its Reveal XT™ Insertable Cardiac Monitor (ICM) in the United States, along with the nation's first implant of the new device. The procedure was conducted by Blair Grubb, M.D., professor of Medicine and Pediatrics at the University of Toledo Medical Center, a renowned heart specialist. The Reveal XT device joins the Reveal® DX ICM as the industry's first insertable cardiac monitors that offer comprehensive remote monitoring capabilities, via the Medtronic CareLink® Network, and which allow physicians to confirm or rule out an imageabnormal heart rhythm. 

“How does an insertable cardiac monitor work?

Once the cardiac monitor is implanted in your upper chest area, it is programmed to continuously monitor your heart’s activity. When a fainting spell occurs, you or your family member should immediately place a small hand-held activator over the cardiac monitor and press a button.

This triggers the device to record the heart’s rhythms before, during, and after the unexplained fainting spell. If your fainting spell is heart-related, your doctor may recommend treatment based on the exact cause.”

First Use Of New Subcutaneous Heart Monitor

Related Medtronic Posts:

Medtronic Announces Launch Of X-Stop® Peek IPD® System For U.S. Patients Suffering From Symptoms Of Lumbar Spinal Stenosis

Medtronic Announces First Clinical Data on Occipital Nerve Stimulation for Chronic Migraine to Be Presented at American Headache Society Meeting

Court Rejects Two Medtronic Patents

Medtronic acquires medical device company for $387 million


Post a Comment

Google Analytics Alternative